Sign in
Taking peopleNo phase

Early Transcatheter Mitral Valve Repair After Myocardial Infarction

Key facts

Who runs it
Fundación para la Investigación Biosanitaria del Principado de Asturias
Where
Israel, Italy, Netherlands, and Spain32 sites in 4 countriesChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
250 people, planned
Started
24 Dec 2024
Expected to end
16 Jun 2028
Type of study
Interventional, 2 groups
Treatments tested
  • Early transcatheter edge-to-edge mitral valve repair (TEER).
  • MitraClip
  • Optimal medical treatment
Record updated
20 October 2025

Who can take part

Age
18 years to 99 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Patients with symptomatic moderate to severe or severe MR after acute MI
  • Age > 18 years
  • Based on the following classification recently published in "Transcatheter Mitral Edge-to-Edge Repair for Treatment of Acute Mitral Regurgitation" by M. Shuvy et al. (Can J Cardiol. 2023) patients will be included if categorized in Type 2, 3 or 4:

Who cannot take part

  • Primary MR (e.g. papillary muscle rupture)
  • EF ≤ 25%
  • Accepted for CABG
  • Presence of cardiogenic shock (AMR type 1)

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 99 years old?

This trial has no sites in United States.

It has sites in 4 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

To explore the impact of early transcatheter edge-to-edge repair of acute functional mitral regurgitation after myocardial infarction on the combined incidence of death and heart-failure associated hospitalisations at one-year follow-up, and quality of life and LV remodelling at two-year follow-up.

The 2 groups in the trial

  • TEER + OMTTreatment being tested

    Early transcatheter edge-to-edge mitral valve repair (TEER) plus optimal medical treatment

    Treatment: Early transcatheter edge-to-edge mitral valve repair (TEER)., MitraClip, and Optimal medical treatment

  • OMTOther group

    Optimal medical treatment

    Treatment: Optimal medical treatment

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Fit questions
Built from NCT06282042, who can take part
Record updated
20 October 2025